Blog | HemaCare

Cancer CAR T Cell Therapy Adapted to Help Fight Threatening Fungal Infections

CAR T Cell Therapy Attacks Migrant Cells in the Immune System

Genetically Engineered T-Cells May Lead to a New Immunotherapy for Type 1 Diabetes

The Beginners Guide to COVID-19 mRNA Vaccines

The Beginners Guide to COVID-19 mRNA Vaccines

COVID-19 Vaccine Series Launch Heralds New Era of Research

New Study Suggests Hematopoietic Stem Cells Transplantation is Effective for Patients with SPSD

"Invisible" Stem Cells May Help Enhance Immunotherapies to Destroy Tumors

Scientists Capture NK Cells to Harvest Exosomes in the Fight Against Cancer

Stem-like CD8 T Cell Reservoir Plays Critical Role in Protecting and Sustaining Anti-tumor T-Cells

STAT5 Proteins May Play a Critical Role in Effective Anti-Tumor Immune Response

Higher Post-Immunotherapy Survival Rate in Cases of Recurrent Glioblastoma Linked to Low TMB

Ocrevus Lessens Pro-Inflammatory T-Cells in PPMS

Researchers Use Single-Cell Sequencing to Study Clonal Diversity of Acute Myeloid Leukemia

New Research Shows the Vital Role Metabolic Signaling Plays in Regulating Specialized T Cells

Modification of STAT3 Expression by HIV-1 Proviral Integration May Encourage Ex Vivo T-Cell Overgrowth

SARS-CoV-2 Variants are Being Recognized by T Cells

New Technique Could Help Scientists Identify Rare T Cells and Advance T Cell Therapies

Killer T Cells May Be the Key to COVID-19 Immunity Against Emerging Variants

Cryopreserved Immune Cells Tip the Scales Toward Success

New Treatment Options May Lead to Dramatic Increase in Survival Rate for Patients Receiving Immunotherapy for NSCLC

HemaCare Publication Shines the Spotlight on Dedicated Donors

Granulocytes–Just Say No!

HemaCare Isolated Immune Cells Bring Quality To Your Doorstep

HemaCare’s Super Donors to the Rescue!

Diabetes Researchers Discover High Levels of Predatory CD8+ T Cells in the Pancreas of Healthy People

HemaCare Starting Material Plays Key Role in Dendritic Cell Assay Development

Hematopoietic Stem Cell Mutations May Lead to Increased Risk for Leukemia and Heart Disease

Cryopreserved T Cells Hold Answers to COVID-19 Immunity

Researchers Discover Antigen-Specific pTfh Cells in Patients with COVID-19

HemaCare Macrophages Help Solve Mysteries of Immune Regulation

Stronger Together: HemaCare and Cellero Join Forces

Researchers Discover New Way to Empower T Cells' Anti-Tumor Activity

T Cell Analysis Could Predict Type I Diabetes Immunotherapy Response

Happy New Year! The Top Ten HemaCare Blogs of 2020

Patients with Advanced Bladder Cancer May See Prolonged Survival with Immunotherapy

Clinical Trials Begin for CAR-T Immunotherapy for Metastatic Prostate Cancer

T Cells May Help in Reducing COVID-19 Severity

Combining Microbial Therapy with Immunotherapy May Help the Immune System Attack Cancer Cells

HemaCare Leukopaks Used to Evaluate CAR T Cell Therapy Potency

The University of Minnesota Investigates Using NK Cells to Fight Covid-19

COVID-19 Associated Delays Impact Quality of Cryopreserved CD34+ Products

Linagliptin Improves CD34+ Stem Cell Function in Patients with Type II Diabetes and Chronic Kidney Disease

Breast Cancer Cells Alter Function of NK Cells to Prevent Metastases

HemaCare Human Bone Marrow Employed in Groundbreaking Cancer Detection Study

Engineering T Cells to Target Senescence for Improved Therapeutic Options

Editing NK Cells Produces More Potent Cancer Killers

Oxford's COVID-19 Vaccine Produces a Strong Positive Immune Response in Early Results

T Cells Could Play a Protective Role Against COVID-19

HemaCare PBMCs Provide Vital Data for CAR T Cell Primate Study

Study Looks at MSCs for Wound Healing in Diabetic Rats

Therapeutic Targeting of Follicular T Cells with Chimeric Antigen

HemaCare PBMCs Aid Development of Novel Cancer Immunotherapy

Customized Immunotherapy Shows Promise for Lung Cancer

Inhibiting MDR1 Could Cripple Natural Immune Response to Cancers

Studies Look at Mesenchymal Stem Cells for Treating Preeclampsia

Cryopreserved Leukopaks: Finding the Best Fit for Your Research Needs

HemaCare Donor Recruitment Helps Solve Lung Cancer Puzzle

Mimicking Memory Cell Activation

Exploring CAR-T and TCR-T Therapies for COVID-19 Treatment

Could Mesenchymal Stem Cells Treat Patients Severely Ill from COVID-19?

Treatment with Mesoblast’s Remestemcel-L Leads to an 83% Survival Rate in Patients with ARDS

Possible New Improvements for Acute Myeloid Leukemia Treatment

BCMA CAR T Cells Response in Myeloma Improved by Gamma Secretase Inhibitor

Could Stem Cell Therapy Be the Better Treatment for MS?

FDA Grants New Therapy for Sickle Cell Treatment

CAR NK-Cell Therapy for Patients with NHL and CLL

MLL Gene May Drive Hematopoietic Stem Cell Production

Finding Therapy for Sex-Biased Autoimmune Conditions

HemaCare PBMCs Aid HPV Cancer Research

X-ALD Patients Hope to See Results With Cell-Based Gene Therapy

Discussing Therapeutic Options for Novel Coronavirus (COVID-19)

Memory T Cells in Mice Aid Immunity During Periods of Food Scarcity

HemaCare Bone Marrow Mononuclear Cells Help Unravel Immunological Mystery

HemaCare PBMCs Power Exosome-based Cancer Immunotherapy

New T Cell Therapy Raises Hopes for Universal Cancer Treatment

Could Immunotherapy Effectively Treat Diseases Other Than Cancer

Metabolism, Immune Systems, and Pregnancy: What T Cells Are Revealing

Mobilized HemaCare Leukopaks Aid New T Cell Therapy Development

The Promise of Stromal Cells (Mesenchymal Stem Cells)

CD34+ Stem Cells Used to Study Carbon Nanoparticle Absorption

Could Cell Therapy Boost Cardiac Function in DMD Patients?

HemaCare Publication Highlights Role of Cell Therapy Starting Materials

Nanotechnology for Acute Kidney Injury

Tests in New Immunotherapy Targets Macrophages Instead of Cancer Cells

Happy New Year! The Top Ten HemaCare Blogs of 2019

CAR T Cell Drug Touts Long-Term Survival Rates

HemaCare Publication Shines Spotlight on Healthy Donors

University of Minnesota Opened New NK-Cell Immunotherapy Clinical Trial

NK Cells Used to Find Cause of Fatal Hepatitis A Cases

HemaCare Healthy Donor Cells Aid New CAR T Cell Design

What Impacts Starting Material Quality? Part 3: Defining the Balance Between Purity and Yield

What Impacts Starting Material Quality? Part 2: Apheresis Best Practices

What Impacts Starting Material Quality? Part 1: Donor Variability

New Blood Test Developed for Chronic Fatigue Syndrome

How Are Stem Cells Mobilized?

iCART and iPSCs Opens New Doors in Cell Therapy

Healthy Microbiomes May Boost Activity of Killer Immune Cells

Is an Unusual Immune Cell the Cause of Type I Diabetes?

Immunotherapy for Breast Cancer on the Horizon

NK Cells May Form Adaptive Memories

The Role of Lymph Node Cells in Immune Tolerance

The Changing Landscape of Clinical Approval

Extracellular Vesicles Boost Grafting Ability in Cells

Medicare’s Decision to Cover Cell Therapy Treatments

PBMC Reprogramming Opens Doors in Regenerative Medicine

Can TRuCs Beat CARs?

Mobilization Mechanics: The Complex World of Stem Cell Mobilization

NK Cell Clinical Trial Begins for Incurable Cancer

How Transplanted Human Bone Marrow Cells May Improve ALS Therapy

New HemaCare Publication Stipulates the Need for Healthy Donor Tissue

Better Immunotherapy Research Needed for Elderly Lung Cancer Patients

HemaCare Starting Material Provides Real-Time Data on Therapeutic Cell Quality

Positioning Cell Therapies for Success -Part 2: Supply Chain Requirements

Positioning Cell Therapies for Success-Part 1: Ensuring Quality and Consistency

HemaCare Leukopaks Used for Production of Allogeneic CAR T cells

HemaCare Aids Strategy for Boosting Gene Therapy Efficiency

Minimizing Risk from the Start: HemaCare Publication Spotlights Starting Material Logistics

HemaCare Leukopaks Support Novel Gene Editing Strategy

HemaCare Leukopaks Aid T Cell Cryopreservation Study

Improving Immune Checkpoint Therapy for Melanoma

The Connection Between Dendritic Cells and Anaphylaxis

Stem Cells Working on Matters of the Heart

Can Stem Cells Be A Game Changer for MS Patients?

HemaCare Leukopaks Employed for Development of Bi-Specific Antibodies for Cancer Immunotherapy

Developing Treatments for Sclerosis Patients

STEM Outreach - HemaCare Style

Atopic Dermatitis More Severe for African Americans

Combat Viral and Bacterial Infections with Targeted Immune Cells

FDA Policy Changes will Accelerate Cell and Gene Therapy Approvals

HemaCare Starting Material Aids Discovery of New Brain Tumor Treatment Strategy

Cell Interactions for Immunotherapy and More

HemaCare Rings in the New Year with New Headquarters and a Cutting-Edge Collection Center

2018 Nobel Prize in Medicine Recognizes Immunotherapy Researchers

HemaCare Immune Cells Ace Cytotoxicity Assay used to Screen Therapeutic Antibodies

HemaCare Immune Cells Facilitate Study on Gene Activation During Stem Cell Development

HemaCare Memory B Cells Recall Their Primary Function

Happy New Year! The Top 10 HemaCare Blogs of 2018

Brrr, It's Cold Outside! Managing the Cell Therapy Cold Chain

HemaCare Bone Marrow Tissue Boosts Development of Cell Therapy for Sickle Cell Disease

How Dendritic Cells May Shed Light on Organ Rejection

Cells May Cooperate to Treat Cancers

Chronic Stress May Increase Cellular Aging in Women

HIV Cell Therapy in Development

HemaCare Publication Illustrates Optimal Apheresis Collection Techniques

How Stem Cell Therapy is Helping Prolong Lives

Mom's Cytotoxic T Cells from Dengue May Protect Babies Against Zika

Research on Universal Cancer Vaccine

Can Stem Cells Treat Lyme Disease?

Targeting T Cells to Treat IBD

Combination of Cells Improves Immunotherapy

Treatment of Fibromyalgia as an Inflammatory Disease

How to Optimize Material Quality for Cellular Therapeutics

Treating Glioblastoma with CAR-T Immunotherapy

Two-Pronged Antibodies Draw Immune Killers to Cancer Cells

Brain Cancer Vaccine Could Improve Prognosis

Improving the Efficiency of Clinical Gene Therapy

What's New in Psychiatric and Neurologic Disorder Immunotherapy?

Personalized Vaccine Fights Ovarian Cancer

Stem Cell Method Sheds Light on Heart Disease

New Improvements for Prostate Cancer Immunotherapy

PBMCs and Psoriasis Treatments

New Cancer Immunotherapy Approach Seeks to Supercharge T cell Activity

Stem Cells May Aid ALS Treatment

T Cells Can Help Reduce Inflammation in Autoimmune Conditions

Research Advances in Stem Cell Therapy for Rheumatic Diseases

Prevent Recurring Tumors with Immunotherapy

Dendritic Cells Change Game for Immunotherapy for Cancer Patients

Genes That Enable Adult Cells to Divide and Multiply May Help Regenerate Heart Tissue

New Progress in Immunotherapy Strategies

Promising Treatment for Multiple Myeloma on the Horizon

Stem Cell-Like Function of Adult Immune Cells Stimulate Healing

Improved Cancer Immunotherapy Possible with Dendritic Cell Vaccines

Progress in Sickle Cell Cure Research

What Are the Benefits to Using Disease State Samples?

The HIV Epidemic: Research Studies Open Doors To New Antibody Treatment Options

Biological Scaffolding Speeds Ex Vivo T Cell Expansion

The Role of PBMCs in Chronic Fatigue

How T Cells Navigate the Bloodstream

Immunotherapy Via Remote Control

HemaCare to supply pre-screened PBMCs to facilitate engraftment of human cells for Charles River’s new NCG mouse humanization kit.

Study of Key Cellular Process in Cardiovascular Disease Now Possible with Stem Cell Research

Targeting Special Dendritic Cells to Treat Scleroderma

Biologic Could Offer New Hope for Stem Cell Transplants

British Drug Discovery of the Year

Young Blood's Effect on Alzheimer’s Disease

Advances in Immunotherapy May Change Glioblastoma Treatments

Immune Research Innovations Support Multiple Sclerosis Arena

Gene Therapy Tackles Sickle-Cell Disease

Cell Cryopreservation: Key to Optimal Cell Therapy Development and Application

HemaCare’s Top 10 Blog Posts of 2017

Versatility and Specificity of CAR-T Cell Cytokines

CAR-T: The Designer Tumor Therapy Frontier

Receptor tyrosine kinase-like orphan receptor 1-derived peptide as target for the design of cytotoxic T cell-based immunotherapy

Characterization of T Cell Subsets in Adult Minimal Change Disease

Expansion of Antitumor Natural Killer Cells Using Anti-CD16 Antibody and Irradiated Autologous Peripheral Blood Mononuclear Cells

CD5-Marked Dendritic Cells Are Associated with Inflammatory Skin Disease

Therapeutic Gene Editing in CD34+ Stem Cells from Patients with Fanconi Anemia

Structural Differences Associated with the Cytotoxic T-cell Response to an Immunodominant Epitope of the Influenza A Virus

The Effects of Bordetella Adenylate Cyclase Toxin on Dendritic Cells, Macrophages, and Neutrophils Disrupt Host Immunity

All posts

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts